NR4A1 and breast carcinoma: To test that THEMIS2 might regulate hormone receptor positive breast cancer cells, such as MCF7, we performed an additional MTT assay and observed knockdown or overexpress THEMIS2, increase or decrease slightly, respectively, the growth of MCF-7 cells (Supplementary Fig. 22).